Table 6.
Patients | Group | hRV | hCV | InfA |
---|---|---|---|---|
ITT | Carrageenan | 8.8 ± 0.6 | 9.02 ± 0.7 | 8.7 ± 1.0 |
Placebo | 10.7 ± 0.7 | 12.95 ± 0.99 | 12.0 ± 1.2 | |
Difference | 1.9 days* | 3.9 days** | 3.3 days* | |
PP | Carageenan | 8.7 ± 0.7 | 9.1 ± 0.7 | 9 ± 1.1 |
Placebo | 10.5 ± 0.8 | 12.2 ± 1.1 | 10.7 ± 1.5 | |
Difference | 1.8 days* | 3.1 days** | 1.7 days |
*:p < 0.05; **:p < 0.01.